Skip to main content
logo
Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
47.25
+2.82 (6.35%)
Oct 19, 2026, 2:04 PM EDT - Market open

Pulse Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.190.35--0.71.42
Revenue Growth
-----50.63%-
Gross Profit
0-0.19---11.24-0.55
Operating Income
-83.64-76.94-56.26-43.57-58.06-63.01
Net Income
-80.06-72.78-53.59-42.21-58.51-63.66
Earnings Per Share
-1.18-1.08-0.92-0.85-1.72-2.28
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
101.6280.74118.0444.3761.1428.61
Total Debt
6.777.538.99.1475.9611.25
Net Cash (Debt)
94.8573.21109.1435.22-14.8217.36
Net Cash Growth
-3.32%-32.93%209.87%--90.42%
Net Cash Per Share
1.391.091.870.71-0.440.62

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-61.1-54.12-36.34-33.04-47.01-54.1
Capital Expenditures
-0.29-0.32-0.13-0.12-0.4-0.44
Free Cash Flow
-61.39-54.44-36.47-33.16-47.41-54.53
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
0.25%-54.00%----38.79%
Operating Margin
-7058.40%-21982.57%---8293.86%-4443.87%
Pretax Margin
-6755.78%-20794.57%---8357.86%-4489.42%
Profit Margin
-6755.78%-20794.57%---8357.86%-4489.42%
FCF Margin
-5180.42%-15553.43%---6773.43%-3845.84%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2806.862658.43--147.32309.48